Matches in SemOpenAlex for { <https://semopenalex.org/work/W3131853407> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W3131853407 abstract "Studies of drug utilization in patients with diabetes, a chronic disease that can be treated with a wide range of available medicines, have attracted substantial social and clinical interest.To characterize antidiabetic medicine consumption between 2005 and 2017, to evaluate the trends of these medicines in mainland Portugal, and to compare district consumption. An additional objective was to perform a statistical analysis on drug consumption in different regions of Portugal.A descriptive, longitudinal observational study; the setting was mainland Portugal ( excluding Azores and Madeira). Each medicine has a respective defined daily dose (DDD). The sum of the DDD, provides the annual consumption in terms of the DDD for each district each year. When calculating the annual average for the resident district population and the number of days in a year, the denominator is expressed as 1000 inhabitants per day (TID).The DDD/TID for mainland Portugal (for all districts) between 2005 and 2017 for antidiabetic medicines. Information was obtained from the official database of prescription medicine invoices with reimbursement in mainland Portugal.In mainland Portugal, the antidiabetic medicine consumption was 49.3 DDD/TID in 2005 and 88.2 DDD/TID in 2017. The consumption of insulins and their analogs increased from 10.8% to 17.4% compared to the total consumption of antidiabetic medicines. In 2017, the level of biguanide consumption was 23.1 DDD/TID, that of sulphonylurea consumption was 15.8 DDD/TID, that of DPP-4 inhibitor consumption was 6.8 DDD/TID, and that of SGLT2 inhibitor consumption was 3.0 DDD/TID. The oral consumption of fixed-dose combinations reached 21.4 DDD/TID. After employing a geographical division between north and south and between coastal and inland regions, the consumption of several different drugs showed statistically significant differences.When comparing 2017 with 2005, the panorama was quite different, with higher levels of consumption of antidiabetic medicines, insulins and their analogs, noninsulin medicines, long-acting and fast-acting insulins and their analogs, metformin, DPP-4 inhibitors and, mainly, metformin combined with a DPP-4 inhibitor. The SGLT2 inhibitors achieved a representative consumption. Different consumption patterns may be related to sociodemographic factors or to clinical practices." @default.
- W3131853407 created "2021-03-01" @default.
- W3131853407 creator A5032876960 @default.
- W3131853407 creator A5067020663 @default.
- W3131853407 creator A5071766118 @default.
- W3131853407 date "2021-02-24" @default.
- W3131853407 modified "2023-10-16" @default.
- W3131853407 title "Consumption of antidiabetic medicines in Portugal: results of a temporal data analysis of a thirteen‐year study (2005–2017)" @default.
- W3131853407 cites W2048274344 @default.
- W3131853407 cites W2086174314 @default.
- W3131853407 cites W2155887474 @default.
- W3131853407 cites W2530717584 @default.
- W3131853407 cites W2582026922 @default.
- W3131853407 cites W2620566936 @default.
- W3131853407 cites W3081494271 @default.
- W3131853407 cites W4235479662 @default.
- W3131853407 doi "https://doi.org/10.1186/s12902-021-00686-w" @default.
- W3131853407 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7905618" @default.
- W3131853407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33627117" @default.
- W3131853407 hasPublicationYear "2021" @default.
- W3131853407 type Work @default.
- W3131853407 sameAs 3131853407 @default.
- W3131853407 citedByCount "3" @default.
- W3131853407 countsByYear W31318534072022 @default.
- W3131853407 countsByYear W31318534072023 @default.
- W3131853407 crossrefType "journal-article" @default.
- W3131853407 hasAuthorship W3131853407A5032876960 @default.
- W3131853407 hasAuthorship W3131853407A5067020663 @default.
- W3131853407 hasAuthorship W3131853407A5071766118 @default.
- W3131853407 hasBestOaLocation W31318534071 @default.
- W3131853407 hasConcept C107029721 @default.
- W3131853407 hasConcept C126322002 @default.
- W3131853407 hasConcept C134018914 @default.
- W3131853407 hasConcept C144024400 @default.
- W3131853407 hasConcept C160735492 @default.
- W3131853407 hasConcept C162324750 @default.
- W3131853407 hasConcept C166957645 @default.
- W3131853407 hasConcept C191935318 @default.
- W3131853407 hasConcept C205649164 @default.
- W3131853407 hasConcept C23131810 @default.
- W3131853407 hasConcept C2426938 @default.
- W3131853407 hasConcept C2776865356 @default.
- W3131853407 hasConcept C2779703844 @default.
- W3131853407 hasConcept C2781300146 @default.
- W3131853407 hasConcept C2908647359 @default.
- W3131853407 hasConcept C30772137 @default.
- W3131853407 hasConcept C36289849 @default.
- W3131853407 hasConcept C50522688 @default.
- W3131853407 hasConcept C555293320 @default.
- W3131853407 hasConcept C556039675 @default.
- W3131853407 hasConcept C71924100 @default.
- W3131853407 hasConcept C98274493 @default.
- W3131853407 hasConcept C99454951 @default.
- W3131853407 hasConceptScore W3131853407C107029721 @default.
- W3131853407 hasConceptScore W3131853407C126322002 @default.
- W3131853407 hasConceptScore W3131853407C134018914 @default.
- W3131853407 hasConceptScore W3131853407C144024400 @default.
- W3131853407 hasConceptScore W3131853407C160735492 @default.
- W3131853407 hasConceptScore W3131853407C162324750 @default.
- W3131853407 hasConceptScore W3131853407C166957645 @default.
- W3131853407 hasConceptScore W3131853407C191935318 @default.
- W3131853407 hasConceptScore W3131853407C205649164 @default.
- W3131853407 hasConceptScore W3131853407C23131810 @default.
- W3131853407 hasConceptScore W3131853407C2426938 @default.
- W3131853407 hasConceptScore W3131853407C2776865356 @default.
- W3131853407 hasConceptScore W3131853407C2779703844 @default.
- W3131853407 hasConceptScore W3131853407C2781300146 @default.
- W3131853407 hasConceptScore W3131853407C2908647359 @default.
- W3131853407 hasConceptScore W3131853407C30772137 @default.
- W3131853407 hasConceptScore W3131853407C36289849 @default.
- W3131853407 hasConceptScore W3131853407C50522688 @default.
- W3131853407 hasConceptScore W3131853407C555293320 @default.
- W3131853407 hasConceptScore W3131853407C556039675 @default.
- W3131853407 hasConceptScore W3131853407C71924100 @default.
- W3131853407 hasConceptScore W3131853407C98274493 @default.
- W3131853407 hasConceptScore W3131853407C99454951 @default.
- W3131853407 hasIssue "1" @default.
- W3131853407 hasLocation W31318534071 @default.
- W3131853407 hasLocation W31318534072 @default.
- W3131853407 hasLocation W31318534073 @default.
- W3131853407 hasLocation W31318534074 @default.
- W3131853407 hasOpenAccess W3131853407 @default.
- W3131853407 hasPrimaryLocation W31318534071 @default.
- W3131853407 hasRelatedWork W1970444990 @default.
- W3131853407 hasRelatedWork W1997402220 @default.
- W3131853407 hasRelatedWork W2106308465 @default.
- W3131853407 hasRelatedWork W2121619948 @default.
- W3131853407 hasRelatedWork W2191730108 @default.
- W3131853407 hasRelatedWork W3009141905 @default.
- W3131853407 hasRelatedWork W3131853407 @default.
- W3131853407 hasRelatedWork W3209339069 @default.
- W3131853407 hasRelatedWork W4252040781 @default.
- W3131853407 hasRelatedWork W2519764742 @default.
- W3131853407 hasVolume "21" @default.
- W3131853407 isParatext "false" @default.
- W3131853407 isRetracted "false" @default.
- W3131853407 magId "3131853407" @default.
- W3131853407 workType "article" @default.